Nykredit A S Invests $17.26 Million in Cigna Group $CI

Nykredit A S bought a new stake in shares of Cigna Group (NYSE:CI) in the second quarter, Holdings Channel reports. The institutional investor bought 62,599 shares of the health services provider’s stock, valued at approximately $17,257,000.

Several other large investors also recently bought and sold shares of CI. Evercore Wealth Management LLC lifted its position in Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after purchasing an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC raised its position in shares of Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after buying an additional 36 shares in the last quarter. Independence Bank of Kentucky raised its position in shares of Cigna Group by 2.6% during the 2nd quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after buying an additional 37 shares in the last quarter. IHT Wealth Management LLC lifted its holdings in shares of Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after acquiring an additional 38 shares during the last quarter. Finally, Whetstone Capital Advisors LLC grew its position in Cigna Group by 4.9% in the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after acquiring an additional 39 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 23,012 shares of company stock valued at $6,386,550 over the last three months. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on CI shares. Wolfe Research reissued an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Mizuho boosted their target price on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Barclays raised their price target on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Piper Sandler dropped their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Stock Down 1.4%

Shares of NYSE CI opened at $282.24 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The firm has a 50-day simple moving average of $283.51 and a two-hundred day simple moving average of $281.07. The company has a market cap of $74.58 billion, a P/E ratio of 11.68, a PEG ratio of 0.98 and a beta of 0.31. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the business posted $7.20 earnings per share. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts anticipate that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.